Novavax sheds a quarter of its value as sales look to remain pressured Novavax, Inc. (NASDAQ:NVAX) shares fell over 27% on Wednesday as the Covid-19 vaccine maker warned of slowing sales ahead after…
Novavax: Kein Investment wert - Aktienanalyse Kulmbach (www.aktiencheck.de) - Novavax-Aktienanalyse von "Der Aktionär": Thomas Bergmann vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…